
[Cancer Research 47, 1302-1307, March 1, 1987]
© 1987 American Association for Cancer Research
Differential Effects of Various Protein Kinase C Activators on Protein Phosphorylation in Human Acute Myeloblastic Leukemia Cell Line KG-1 and Its Phorbol Ester-resistant Subline KG-1a1
Zoltan Kiss,
Eva Deli,
Mamoru Shoji,
H. Phillip Koeffler2,
George R. Pettit,
William R. Vogler and
J. F. Kuo
Departments of Pharmacology [Z. K., E. D., J. F. K.] and Medicine (Hematology and Oncology) [M. S., W. R. V.], Emory University School of Medicine, Atlanta, Georgia 30322; Department of Medicine (Hematology/Oncology) [H. P. K.], University of California at Los Angeles, Los Angeles, California 90024; and Cancer Research Institute and Department of Chemistry [G. R. P.], Arizona State University, Tempe, Arizona 85287
Human myeloid leukemia KG-1 cells are induced to differentiate to macrophage-like cells by tumor-promoting phorbol esters, such as 12-O-tetradecanoylphorbol-13-acetate (TPA). Cells from the cloned subline, KG-1a, unlike the parental line, are resistant to the differentiating effect of TPA. In the present studies, we investigated in these cells protein phosphorylation stimulated by various protein kinase C activators, including 1-oleoyl-2-acetylglycerol in the presence of the diacylglycerol kinase inhibitor R59022, TPA, mezerein, and bryostatin. All the agents stimulated, to a greater extent and with a higher potency, phosphorylation of several proteins in KG-1 cells than in KG-1a cells. On the other hand, these agents markedly stimulated phosphorylation of other proteins in KG-1a cells compared to that in KG-1 cells. The findings indicated that the actions of the diacylglycerol, 1-oleoyl-2-acetylglycerol, and the non-metabolizable activators (TPA, mezerein, and bryostatin) were very similar but not fully equivalent; and that KG-1a cells exhibited altered (increased or decreased) phosphorylation patterns, perhaps related to the TPA resistance characteristic of this subline of cells.
1 Supported by USPHS Research Grants CA-36777, HL-15696, and NS-17608 (J. F. K.), CA-26038 and CA-32737 (H. P. K.), CA-29850 (W. R. V.), and CA-16094 and N01-CM-97262 (G. R. P.).
2 Recipient of USPHS Research Career Development Award and a member of Johnson Cancer Center.
Received 7/30/86.
Revised 11/13/86.
Accepted 12/ 1/86.
This article has been cited by other articles:

|
 |

|
 |
 
D. C. St. Louis, J. B. Woodcock, G. Fransozo, P. J. Blair, L. M. Carlson, M. Murillo, M. R. Wells, A. J. Williams, D. S. Smoot, S. Kaushal, et al.
Evidence for Distinct Intracellular Signaling Pathways in CD34+ Progenitor to Dendritic Cell Differentiation from a Human Cell Line Model
J. Immunol.,
March 15, 1999;
162(6):
3237 - 3248.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1987 by the American Association for Cancer Research.